{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:26Z","timestamp":1792787906505,"version":"4.5.0"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.cca.2019.02.022","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T20:42:58Z","timestamp":1550781778000},"page":"36-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":409,"special_numbering":"C","title":["Myeloperoxidase \u2013 A bridge linking inflammation and oxidative stress with cardiovascular disease"],"prefix":"10.1016","volume":"493","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8725-055X","authenticated-orcid":false,"given":"Gjin","family":"Ndrepepa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2019.02.022_bb0005","first-page":"339","volume":"1","author":"Schoenbein","year":"1855","journal-title":"Verh. Naturforsch. Ges. Basel"},{"key":"10.1016\/j.cca.2019.02.022_bb0010","first-page":"417","article-title":"Die pyrogene substanz. Vorleufige Mitteilung","volume":"6","author":"Klebs","year":"1868","journal-title":"Cbl. Med. Wiss."},{"key":"10.1016\/j.cca.2019.02.022_bb0015","first-page":"373","article-title":"Contribution a l'etude des ferments oxydants. Sur la peroxidase du pus","volume":"50","author":"Linossier","year":"1898","journal-title":"C. R. Soc. Biol. Paris"},{"key":"10.1016\/j.cca.2019.02.022_bb0020","first-page":"46","article-title":"The neutrophilic granules of the circulating blood in health and in disease. A preliminary report","volume":"20","author":"Graham","year":"1920","journal-title":"N. Y. State J. Med."},{"key":"10.1016\/j.cca.2019.02.022_bb0025","first-page":"1","article-title":"Verdoperoxidase: a ferment isolated from leucocytes","volume":"2","author":"Agner","year":"1941","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.cca.2019.02.022_bb0030","series-title":"Highly purified milk peroxidase, Arkiv Kemi Mineralogi Geologi 17B","author":"Theorell","year":"1943"},{"key":"10.1016\/j.cca.2019.02.022_bb0035","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1084\/jem.112.6.1005","article-title":"Degranulation of polymorphonuclear leucocytes following phagocytosis of microorganisms","volume":"112","author":"Hirsch","year":"1960","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cca.2019.02.022_bb0040","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0003-9861(62)90321-1","article-title":"Myeloperoxidase of the leucocyte of normal human blood. I. Content and localization","volume":"96","author":"Schultz","year":"1962","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cca.2019.02.022_bb0045","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0005-2744(71)90281-6","article-title":"Chloramines as intermediates of oxidation reaction of amino acids by myeloperoxidase","volume":"235","author":"Zgliczynski","year":"1971","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cca.2019.02.022_bb0050","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1084\/jem.126.6.1063","article-title":"Iodination of bacteria: a bactericidal mechanism","volume":"126","author":"Klebanoff","year":"1967","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cca.2019.02.022_bb0055","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1128\/jb.95.6.2131-2138.1968","article-title":"Myeloperoxidase-halide-hydrogen peroxide antibacterial system","volume":"95","author":"Klebanoff","year":"1968","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.cca.2019.02.022_bb0060","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1089\/ars.2009.2538","article-title":"Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease","volume":"11","author":"van der Veen","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.cca.2019.02.022_bb0065","doi-asserted-by":"crossref","first-page":"11964","DOI":"10.1074\/jbc.275.16.11964","article-title":"X-ray crystal structure and characterization of halide-binding sites of human myeloperoxidase at 1.8 A resolution","volume":"275","author":"Fiedler","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2019.02.022_bb0070","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.abb.2005.09.017","article-title":"Active site structure and catalytic mechanisms of human peroxidases","volume":"445","author":"Furtmuller","year":"2006","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cca.2019.02.022_bb0075","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1128\/iai.55.5.1029-1036.1987","article-title":"Role of high-avidity binding of human neutrophil myeloperoxidase in the killing of Actinobacillus actinomycetemcomitans","volume":"55","author":"Miyasaki","year":"1987","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cca.2019.02.022_bb0080","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2249.1994.tb06579.x","article-title":"Binding of proteinase 3 and myeloperoxidase to endothelial cells: ANCA-mediated endothelial damage through ADCC?","volume":"97","author":"Ballieux","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cca.2019.02.022_bb0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1006848730927","article-title":"Association of myeloperoxidase with heparin: oxidative inactivation of proteins on the surface of endothelial cells by the bound enzyme","volume":"183","author":"Daphna","year":"1998","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cca.2019.02.022_bb0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.matbio.2009.09.005","article-title":"Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan","volume":"29","author":"Rees","year":"2010","journal-title":"Matrix Biol."},{"key":"10.1016\/j.cca.2019.02.022_bb0095","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0014-5793(00)02227-4","article-title":"Myeloperoxidase binds to low-density lipoprotein: potential implications for atherosclerosis","volume":"487","author":"Carr","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cca.2019.02.022_bb0100","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI200421109","article-title":"Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease","volume":"114","author":"Zheng","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2019.02.022_bb0105","doi-asserted-by":"crossref","first-page":"7699","DOI":"10.1073\/pnas.0401712101","article-title":"Albumin mediates the transcytosis of myeloperoxidase by means of caveolae in endothelial cells","volume":"101","author":"Tiruppathi","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cca.2019.02.022_bb0110","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2353\/ajpath.2007.060831","article-title":"Myeloperoxidase interacts with endothelial cell-surface cytokeratin 1 and modulates bradykinin production by the plasma Kallikrein-Kinin system","volume":"171","author":"Astern","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cca.2019.02.022_bb0115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.abb.2006.10.030","article-title":"Differential effects of flavonols on inactivation of alpha1-antitrypsin induced by hypohalous acids and the myeloperoxidase-hydrogen peroxide-halide system","volume":"459","author":"Bouriche","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cca.2019.02.022_bb0120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2249.1997.d01-992.x","article-title":"Binding and inhibition of myeloperoxidase (MPO): a major function of ceruloplasmin?","volume":"108","author":"Segelmark","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cca.2019.02.022_bb0125","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1161\/CIRCULATIONAHA.105.590083","article-title":"Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase","volume":"113","author":"Baldus","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2019.02.022_bb0130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tvjl.2007.08.033","article-title":"Effects of unfractionated and fractionated heparins on myeloperoxidase activity and interactions with endothelial cells: possible effects on the pathophysiology of equine laminitis","volume":"178","author":"de la Rebiere","year":"2008","journal-title":"Vet. J."},{"key":"10.1016\/j.cca.2019.02.022_bb0135","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000132742","article-title":"Assignment of the human myeloperoxidase gene (MPO) to bands q21.3\u2014q23 of chromosome 17","volume":"50","author":"Inazawa","year":"1989","journal-title":"Cytogenet. Cell Genet."},{"key":"10.1016\/j.cca.2019.02.022_bb0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1601-5223.1991.tb00348.x","article-title":"Refinement of localization of the human genes for myeloperoxidase (MPO), protein kinase C, alpha polypeptide, PRKCA, and the DNA fragment D17S21 on chromosome 17q","volume":"115","author":"Latos-Bielenska","year":"1991","journal-title":"Hereditas"},{"key":"10.1016\/j.cca.2019.02.022_bb0145","first-page":"319","article-title":"Localization of myeloperoxidase to the long arm of human chromosome 17: relationship to the 15; 17 translocation of acute promyelocytic leukemia","volume":"1","author":"van Tuinen","year":"1987","journal-title":"Oncogene"},{"key":"10.1016\/j.cca.2019.02.022_bb0150","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood.V90.7.2730","article-title":"An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia","volume":"90","author":"Reynolds","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.022_bb0155","doi-asserted-by":"crossref","first-page":"8300","DOI":"10.1074\/jbc.M311625200","article-title":"Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism","volume":"279","author":"Kumar","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2019.02.022_bb0160","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1074\/jbc.M807731200","article-title":"Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease","volume":"284","author":"Maki","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2019.02.022_bb0165","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.bbrc.2006.08.119","article-title":"The human myeloperoxidase gene is regulated by LXR and PPARalpha ligands","volume":"349","author":"Reynolds","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2019.02.022_bb0170","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/sj.ejhg.5200702","article-title":"Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms","volume":"9","author":"Hoy","year":"2001","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.cca.2019.02.022_bb0175","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.atherosclerosis.2005.10.012","article-title":"Myeloperoxidase genetic polymorphisms modulate human neutrophil enzyme activity: genetic determinants for atherosclerosis?","volume":"188","author":"Chevrier","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2019.02.022_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2018.02.001","article-title":"Biosynthesis of human myeloperoxidase","volume":"642","author":"Nauseef","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cca.2019.02.022_bb0185","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0005-2744(78)90197-3","article-title":"Characterization and quantification of the peroxidase in human monocytes","volume":"525","author":"Bos","year":"1978","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cca.2019.02.022_bb0190","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.abb.2005.08.009","article-title":"Biosynthesis, processing, and sorting of human myeloperoxidase","volume":"445","author":"Hansson","year":"2006","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cca.2019.02.022_bb0195","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cellimm.2015.11.003","article-title":"Myeloperoxidase in human peripheral blood lymphocytes: production and subcellular localization","volume":"300","author":"Okada","year":"2016","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cca.2019.02.022_bb0200","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/S0002-9440(10)63059-3","article-title":"Immunohistochemical detection of myeloperoxidase and its oxidation products in Kupffer cells of human liver","volume":"159","author":"Brown","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cca.2019.02.022_bb0205","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1006\/bbrc.2002.6724","article-title":"Macrophage activation includes high intracellular myeloperoxidase activity","volume":"292","author":"Rodrigues","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2019.02.022_bb0210","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0165-5728(97)00089-1","article-title":"Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis","volume":"78","author":"Nagra","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cca.2019.02.022_bb0215","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1046\/j.1432-1327.2000.01498.x","article-title":"Immunohistochemical evidence for the myeloperoxidase\/H2O2\/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins","volume":"267","author":"Malle","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.cca.2019.02.022_bb0220","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/ki.2015.202","article-title":"Renal participation of myeloperoxidase in antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis","volume":"88","author":"O'Sullivan","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2019.02.022_bb0225","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/pros.21452","article-title":"Intriguing location of myeloperoxidase in the prostate: a preliminary immunohistochemical study","volume":"72","author":"Roumeguere","year":"2012","journal-title":"Prostate"},{"key":"10.1016\/j.cca.2019.02.022_bb0230","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1471-4159.2004.02527.x","article-title":"Neuronal expression of myeloperoxidase is increased in Alzheimer's disease","volume":"90","author":"Green","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cca.2019.02.022_bb0235","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00395-008-0761-9","article-title":"Oxidative stress induces myeloperoxidase expression in endocardial endothelial cells from patients with chronic heart failure","volume":"104","author":"La Rocca","year":"2009","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.cca.2019.02.022_bb0240","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.abb.2018.07.011","article-title":"Myeloperoxidase promotes tube formation, triggers ERK1\/2 and Akt pathways and is expressed endogenously in endothelial cells","volume":"654","author":"Khalil","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cca.2019.02.022_bb0245","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0002-9440(10)64036-9","article-title":"Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes","volume":"158","author":"Sugiyama","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cca.2019.02.022_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2018.03.037","article-title":"The other myeloperoxidase: emerging functions","volume":"649","author":"Vanhamme","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cca.2019.02.022_bb0255","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/13510002.2016.1256119","article-title":"The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture","volume":"22","author":"Teng","year":"2017","journal-title":"Redox Rep."},{"key":"10.1016\/j.cca.2019.02.022_bb0260","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.bcp.2005.02.006","article-title":"Exploitation of the unusual thermodynamic properties of human myeloperoxidase in inhibitor design","volume":"69","author":"Jantschko","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cca.2019.02.022_bb0265","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.freeradbiomed.2011.08.008","article-title":"High plasma thiocyanate levels in smokers are a key determinant of thiol oxidation induced by myeloperoxidase","volume":"51","author":"Morgan","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cca.2019.02.022_bb0270","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/1568026611313020004","article-title":"Myeloperoxidase: expressing inflammation and oxidative stress in cardiovascular disease","volume":"13","author":"Anatoliotakis","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.cca.2019.02.022_bb0275","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1089\/ars.2007.1927","article-title":"Mammalian heme peroxidases: from molecular mechanisms to health implications","volume":"10","author":"Davies","year":"2008","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.cca.2019.02.022_bb0280","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1016\/S0021-9258(19)39293-2","article-title":"Reaction of compound III of myeloperoxidase with ascorbic acid","volume":"265","author":"Marquez","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2019.02.022_bb0285","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1006\/abbi.1993.1440","article-title":"Interaction of acetaminophen with myeloperoxidase intermediates: optimum stimulation of enzyme activity","volume":"305","author":"Marquez","year":"1993","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cca.2019.02.022_bb0290","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3164\/jcbn.11-006FR","article-title":"Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention","volume":"48","author":"Davies","year":"2011","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.cca.2019.02.022_bb0295","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.freeradbiomed.2005.08.019","article-title":"Taurine chloramine is more selective than hypochlorous acid at targeting critical cysteines and inactivating creatine kinase and glyceraldehyde-3-phosphate dehydrogenase","volume":"40","author":"Peskin","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cca.2019.02.022_bb0300","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1161\/01.ATV.0000249394.94588.82","article-title":"Uncoupling of endothelial nitric oxidase synthase by hypochlorous acid: role of NAD(P)H oxidase-derived superoxide and peroxynitrite","volume":"26","author":"Xu","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2019.02.022_bb0305","doi-asserted-by":"crossref","first-page":"41279","DOI":"10.1074\/jbc.M106958200","article-title":"Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase","volume":"276","author":"Fu","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2019.02.022_bb0310","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1042\/BJ20080468","article-title":"Hypothiocyanous acid is a more potent inducer of apoptosis and protein thiol depletion in murine macrophage cells than hypochlorous acid or hypobromous acid","volume":"414","author":"Lloyd","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.cca.2019.02.022_bb0315","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/BJ20100082","article-title":"The myeloperoxidase-derived oxidant HOSCN inhibits protein tyrosine phosphatases and modulates cell signalling via the mitogen-activated protein kinase (MAPK) pathway in macrophages","volume":"430","author":"Lane","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.cca.2019.02.022_bb0320","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.freeradbiomed.2004.04.039","article-title":"Thiocyanate catalyzes myeloperoxidase-initiated lipid oxidation in LDL","volume":"37","author":"Exner","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cca.2019.02.022_bb0325","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/nm1637","article-title":"Protein carbamylation links inflammation, smoking, uremia and atherogenesis","volume":"13","author":"Wang","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.cca.2019.02.022_bb0330","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1172\/JCI5549","article-title":"Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro","volume":"103","author":"Podrez","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2019.02.022_bb0335","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.cca.2019.02.022_bb0340","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCRESAHA.111.257535","article-title":"Multiple roles for neutrophils in atherosclerosis","volume":"110","author":"Soehnlein","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2019.02.022_bb0345","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/CIRCRESAHA.116.309692","article-title":"Neutrophil Extracellular Traps in Atherosclerosis and Atherothrombosis","volume":"120","author":"Doring","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2019.02.022_bb0350","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1177\/2047487318760618","article-title":"Markers of neutrophil extracellular traps are associated with adverse clinical outcome in stable coronary artery disease","volume":"25","author":"Langseth","year":"2018","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.cca.2019.02.022_bb0355","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1182\/blood.V57.5.888.888","article-title":"Hereditary myeloperoxidase deficiency","volume":"57","author":"Kitahara","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.cca.2019.02.022_bb0360","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1001\/jama.286.17.2136","article-title":"Association between myeloperoxidase levels and risk of coronary artery disease","volume":"286","author":"Zhang","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2019.02.022_bb0365","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2362.2007.01908.x","article-title":"Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes","volume":"38","author":"Ndrepepa","year":"2008","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.cca.2019.02.022_bb0370","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.freeradbiomed.2009.04.004","article-title":"Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction","volume":"47","author":"Goldmann","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cca.2019.02.022_bb0375","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jacc.2009.11.050","article-title":"Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography","volume":"55","author":"Heslop","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2019.02.022_bb0380","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/MCA.0b013e32834c5e98","article-title":"Plasma myeloperoxidase concentration predicts the presence and severity of coronary disease in patients with chest pain and negative troponin-T","volume":"22","author":"Rebeiz","year":"2011","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.cca.2019.02.022_bb0385","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2143\/AC.63.2.2029520","article-title":"Plasma myeloperoxidase is related to the severity of coronary artery disease","volume":"63","author":"Duzguncinar","year":"2008","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.cca.2019.02.022_bb0390","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jacc.2007.03.033","article-title":"Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study","volume":"50","author":"Meuwese","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2019.02.022_bb0395","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cca.2008.04.001","article-title":"Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease","volume":"394","author":"Kubala","year":"2008","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2019.02.022_bb0400","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.atherosclerosis.2011.08.029","article-title":"Race-specific associations of myeloperoxidase with atherosclerosis in a population-based sample: the Dallas Heart Study","volume":"219","author":"Chen","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2019.02.022_bb0405","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clinbiochem.2009.07.022","article-title":"Association between myeloperoxidase polymorphisms and its plasma levels with severity of coronary artery disease","volume":"43","author":"Wainstein","year":"2010","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2019.02.022_bb0410","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijcard.2014.03.168","article-title":"Association of myeloperoxidase with total and cardiovascular mortality in individuals undergoing coronary angiography--the LURIC study","volume":"174","author":"Scharnagl","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2019.02.022_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205310","article-title":"Association of monocyte myeloperoxidase with incident cardiovascular disease: the Atherosclerosis Risk in Communities Study","volume":"13","author":"Oyenuga","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2019.02.022_bb0420","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.atherosclerosis.2017.06.007","article-title":"Association of the serum myeloperoxidase\/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: observations from the Dallas Heart Study","volume":"263","author":"Khine","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2019.02.022_bb0425","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/01.CIR.0000090690.67322.51","article-title":"Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes","volume":"108","author":"Baldus","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2019.02.022_bb0430","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa035003","article-title":"Prognostic value of myeloperoxidase in patients with chest pain","volume":"349","author":"Brennan","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2019.02.022_bb0435","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.amjcard.2006.12.060","article-title":"Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome","volume":"99","author":"Cavusoglu","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cca.2019.02.022_bb0440","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/eurheartj\/ehn071","article-title":"Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18","volume":"29","author":"Morrow","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2019.02.022_bb0445","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.ajkd.2006.03.047","article-title":"Serum myeloperoxidase and mortality in maintenance hemodialysis patients","volume":"48","author":"Kalantar-Zadeh","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cca.2019.02.022_bb0450","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/MCA.0b013e328333f50d","article-title":"Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients","volume":"21","author":"Roman","year":"2010","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.cca.2019.02.022_bb0455","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jcmg.2009.05.012","article-title":"Myeloperoxidase, subclinical atherosclerosis, and cardiovascular disease events","volume":"2","author":"Wong","year":"2009","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.cca.2019.02.022_bb0460","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.jacc.2007.02.040","article-title":"Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction","volume":"49","author":"Mocatta","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2019.02.022_bb0465","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1373\/clinchem.2010.152827","article-title":"Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease","volume":"57","author":"Tang","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2019.02.022_bb0470","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.amjcard.2012.10.027","article-title":"Usefulness of cardiac biomarker score for risk stratification in stable patients undergoing elective cardiac evaluation across glycemic status","volume":"111","author":"Tang","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cca.2019.02.022_bb0475","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1373\/clinchem.2011.166827","article-title":"Risk prediction with serial myeloperoxidase monitoring in patients with acute chest pain","volume":"57","author":"Nicholls","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2019.02.022_bb0480","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2006.01.067","article-title":"Myeloperoxidase predicts progression of carotid stenosis in states of low high-density lipoprotein cholesterol","volume":"47","author":"Exner","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2019.02.022_bb0485","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1373\/clinchem.2006.080192","article-title":"Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome","volume":"53","author":"Apple","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2019.02.022_bb0490","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ahj.2007.10.017","article-title":"Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease","volume":"155","author":"Stefanescu","year":"2008","journal-title":"Am. Heart J."},{"key":"10.1016\/j.cca.2019.02.022_bb0495","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.clinbiochem.2009.09.026","article-title":"Myeloperoxidase is not useful for the early assessment of patients with chest pain","volume":"43","author":"Eggers","year":"2010","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2019.02.022_bb0500","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/eurheartj\/ehq468","article-title":"Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial","volume":"32","author":"Scirica","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2019.02.022_bb0505","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1161\/CIRCGENETICS.111.962290","article-title":"Diagnostic and prognostic performance of myeloperoxidase plasma levels compared with sensitive troponins in patients admitted with acute onset chest pain","volume":"5","author":"Rudolph","year":"2012","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.cca.2019.02.022_bb0510","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1084\/jem.20021426","article-title":"Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction","volume":"197","author":"Askari","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cca.2019.02.022_bb0515","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1161\/CIRCULATIONAHA.105.542340","article-title":"Myeloperoxidase-generated oxidants modulate left ventricular remodeling but not infarct size after myocardial infarction","volume":"112","author":"Vasilyev","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2019.02.022_bb0520","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.amjcard.2006.04.018","article-title":"Plasma myeloperoxidase levels in patients with chronic heart failure","volume":"98","author":"Tang","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cca.2019.02.022_bb0525","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.amjcard.2009.01.026","article-title":"Usefulness of myeloperoxidase levels in healthy elderly subjects to predict risk of developing heart failure","volume":"103","author":"Tang","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cca.2019.02.022_bb0530","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ahj.2005.09.020","article-title":"Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure","volume":"152","author":"Ng","year":"2006","journal-title":"Am. Heart J."},{"key":"10.1016\/j.cca.2019.02.022_bb0535","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.freeradbiomed.2007.07.016","article-title":"Activation of polymorphonuclear neutrophils in patients with impaired left ventricular function","volume":"43","author":"Rudolph","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cca.2019.02.022_bb0540","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.jacc.2007.02.053","article-title":"Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure","volume":"49","author":"Tang","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2019.02.022_bb0545","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1373\/clinchem.2009.142257","article-title":"Use of myeloperoxidase for risk stratification in acute heart failure","volume":"56","author":"Reichlin","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2019.02.022_bb0550","first-page":"884","article-title":"Usefulness of serum myeloperoxidase in prediction of mortality in patients with severe heart failure","volume":"10","author":"Michowitz","year":"2008","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.cca.2019.02.022_bb0555","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.freeradbiomed.2009.09.001","article-title":"A myeloperoxidase promoter polymorphism is independently associated with mortality in patients with impaired left ventricular function","volume":"47","author":"Rudolph","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cca.2019.02.022_bb0560","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jacbts.2016.09.004","article-title":"Myeloperoxidase inhibition improves ventricular function and remodeling after experimental myocardial infarction","volume":"1","author":"Ali","year":"2016","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.cca.2019.02.022_bb0565","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1373\/clinchem.2008.108159","article-title":"Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea","volume":"55","author":"Shah","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2019.02.022_bb0570","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/eurheartj\/ehr193","article-title":"Myeloperoxidase deficiency preserves vasomotor function in humans","volume":"33","author":"Rudolph","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2019.02.022_bb0575","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1161\/HYPERTENSIONAHA.109.147231","article-title":"Hyperglycemia and oxidative stress strengthen the association between myeloperoxidase and blood pressure","volume":"55","author":"Van der Zwan","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2019.02.022_bb0580","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/01.HYP.0000222893.85662.cd","article-title":"Angiotensin type-1 receptor A1166C gene polymorphism correlates with oxidative stress levels in human heart failure","volume":"47","author":"Cameron","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2019.02.022_bb0585","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1161\/ATVBAHA.116.307634","article-title":"Neutrophil extracellular traps promote angiogenesis: evidence from vascular pathology in pulmonary hypertension","volume":"36","author":"Aldabbous","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2019.02.022_bb0590","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.97530","article-title":"Myeloperoxidase aggravates pulmonary arterial hypertension by activation of vascular Rho-kinase","volume":"3","author":"Klinke","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.cca.2019.02.022_bb0595","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0008-6363(99)00187-X","article-title":"The role of neutrophils in myocardial ischemia-reperfusion injury","volume":"43","author":"Jordan","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cca.2019.02.022_bb0600","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cardiores.2003.10.011","article-title":"Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury","volume":"61","author":"Vinten-Johansen","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cca.2019.02.022_bb0605","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.freeradbiomed.2004.06.003","article-title":"Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion","volume":"37","author":"Baldus","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cca.2019.02.022_bb0610","first-page":"e11","article-title":"Myeloperoxidase and coronary arterial disease: from research to clinical practice","volume":"91","author":"Roman","year":"2008","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.cca.2019.02.022_bb0615","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179929","article-title":"Relation between high levels of myeloperoxidase in the culprit artery and microvascular obstruction, infarct size and reverse remodeling in ST-elevation myocardial infarction","volume":"12","author":"Stamboul","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2019.02.022_bb0620","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.ahj.2011.01.017","article-title":"Peripheral artery disease, biomarkers, and darapladib","volume":"161","author":"Berger","year":"2011","journal-title":"Am. Heart J."},{"key":"10.1016\/j.cca.2019.02.022_bb0625","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/0003319710385336","article-title":"The ARIC carotid MRI study of blood cellular markers: an inverse association of monocyte myeloperoxidase content with peripheral arterial disease","volume":"62","author":"Matijevic","year":"2011","journal-title":"Angiology"},{"key":"10.1016\/j.cca.2019.02.022_bb0630","doi-asserted-by":"crossref","first-page":"39483","DOI":"10.1038\/srep39483","article-title":"The \"Intermediate\" CD14(++)CD16(+) monocyte subset increases in severe peripheral artery disease in humans","volume":"6","author":"Wildgruber","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2019.02.022_bb0635","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jjcc.2016.02.002","article-title":"The histological characteristics and virtual histology findings of the tissues obtained by a distal protection device during endovascular therapy for peripheral artery disease","volume":"69","author":"Maezawa","year":"2017","journal-title":"J. Cardiol."},{"key":"10.1016\/j.cca.2019.02.022_bb0640","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.atherosclerosis.2008.01.014","article-title":"In concomitant coronary and peripheral arterial disease, inflammation of the affected limbs predicts coronary artery endothelial dysfunction","volume":"201","author":"Brevetti","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2019.02.022_bb0645","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/ndt\/gfv418","article-title":"Traditional and non-traditional risk factors for incident peripheral arterial disease among patients with chronic kidney disease","volume":"31","author":"Chen","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2019.02.022_bb0650","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1358863X08101999","article-title":"Association of serum myeloperoxidase with the ankle-brachial index and peripheral arterial disease","volume":"14","author":"Ali","year":"2009","journal-title":"Vasc. Med."},{"key":"10.1016\/j.cca.2019.02.022_bb0655","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/ajh\/hps073","article-title":"Associations of candidate biomarkers of vascular disease with the ankle-brachial index and peripheral arterial disease","volume":"26","author":"Ye","year":"2013","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.cca.2019.02.022_bb0660","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/eurheartj\/ehm587","article-title":"Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease","volume":"29","author":"Brevetti","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2019.02.022_bb0665","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2362.2011.02601.x","article-title":"Plasma myeloperoxidase level and peripheral arterial disease","volume":"42","author":"Haslacher","year":"2012","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.cca.2019.02.022_bb0670","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1161\/01.STR.25.7.1469","article-title":"Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion","volume":"25","author":"Matsuo","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.cca.2019.02.022_bb0675","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/jcbfm.2014.222","article-title":"Myeloperoxidase propagates damage and is a potential therapeutic target for subacute stroke","volume":"35","author":"Forghani","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.cca.2019.02.022_bb0680","article-title":"Reducing myeloperoxidase activity decreases inflammation and increases cellular protection in ischemic stroke","author":"Kim","year":"2018","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.cca.2019.02.022_bb0685","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1124\/jpet.116.235127","article-title":"Myeloperoxidase inhibition increases neurogenesis after ischemic stroke","volume":"359","author":"Kim","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cca.2019.02.022_bb0690","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.cca.2018.10.026","article-title":"Serum myeloperoxidase concentrations for outcome prediction in acute intracerebral hemorrhage","volume":"487","author":"Zheng","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2019.02.022_bb0695","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2018.02.012","article-title":"Serum matrix metalloproteinase-8, tissue inhibitor of metalloproteinase and myeloperoxidase in ischemic stroke","volume":"271","author":"Palm","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2019.02.022_bb0700","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0021-9150(02)00041-2","article-title":"Myeloperoxidase polymorphisms in brain infarction. Association with infarct size and functional outcome","volume":"167","author":"Hoy","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2019.02.022_bb0705","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1093\/brain\/awx220","article-title":"Genetic variants influencing elevated myeloperoxidase levels increase risk of stroke","volume":"140","author":"Phuah","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.cca.2019.02.022_bb0710","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1161\/STROKEAHA.109.559567","article-title":"Inflammatory biomarkers of vascular risk as correlates of leukoariosis","volume":"40","author":"Wright","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.cca.2019.02.022_bb0715","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1161\/STROKEAHA.117.017965","article-title":"Association of osteopontin, neopterin, and myeloperoxidase with stroke risk in patients with prior stroke or transient ischemic attacks: results of an analysis of 13 biomarkers from the stroke prevention by aggressive reduction in cholesterol levels trial","volume":"48","author":"Ganz","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.cca.2019.02.022_bb0720","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1161\/STROKEAHA.114.004956","article-title":"Myeloperoxidase in human intracranial aneurysms: preliminary evidence","volume":"45","author":"Gounis","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.cca.2019.02.022_bb0725","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1161\/STROKEAHA.114.008589","article-title":"Myeloperoxidase is increased in human cerebral aneurysms and increases formation and rupture of cerebral aneurysms in mice","volume":"46","author":"Chu","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.cca.2019.02.022_bb0730","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fphys.2012.00214","article-title":"Fibrosis in atrial fibrillation - role of reactive species and MPO","volume":"3","author":"Friedrichs","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cca.2019.02.022_bb0735","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1161\/CIRCULATIONAHA.104.475194","article-title":"Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation","volume":"111","author":"Ishii","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2019.02.022_bb0740","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00392-011-0383-3","article-title":"Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation","volume":"101","author":"Richter","year":"2012","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.cca.2019.02.022_bb0745","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nm.2124","article-title":"Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation","volume":"16","author":"Rudolph","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.cca.2019.02.022_bb0750","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00059-015-4335-y","article-title":"Platelet hyperaggregability in patients with atrial fibrillation. Evidence of a background proinflammatory milieu","volume":"41","author":"Procter","year":"2016","journal-title":"Herz"},{"key":"10.1016\/j.cca.2019.02.022_bb0755","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112486","article-title":"Multiple biomarkers and atrial fibrillation in the general population","volume":"9","author":"Schnabel","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2019.02.022_bb0760","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/CIRCRESAHA.117.310870","article-title":"Myeloperoxidase mediates postischemic arrhythmogenic ventricular remodeling","volume":"121","author":"Mollenhauer","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2019.02.022_bb0765","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.atherosclerosis.2014.10.020","article-title":"Coronary thrombus composition: links with inflammation, platelet and endothelial markers","volume":"237","author":"Sadowski","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2019.02.022_bb0770","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00414-009-0324-0","article-title":"Time-dependent appearance of intrathrombus neutrophils and macrophages in a stasis-induced deep vein thrombosis model and its application to thrombus age determination","volume":"123","author":"Nosaka","year":"2009","journal-title":"Int. J. Legal Med."},{"key":"10.1016\/j.cca.2019.02.022_bb0775","doi-asserted-by":"crossref","first-page":"M677","DOI":"10.1097\/00002480-199609000-00073","article-title":"Neutrophils are the initial cell type identified in deep venous thrombosis induced vein wall inflammation","volume":"42","author":"Downing","year":"1996","journal-title":"ASAIO J."},{"key":"10.1016\/j.cca.2019.02.022_bb0780","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1553-2712.2008.00204.x","article-title":"Tandem measurement of D-dimer and myeloperoxidase or C-reactive protein to effectively screen for pulmonary embolism in the emergency department","volume":"15","author":"Mitchell","year":"2008","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.cca.2019.02.022_bb0785","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00392-010-0247-2","article-title":"Impact of therapy with statins, beta-blockers and angiotensin-converting enzyme inhibitors on plasma myeloperoxidase in patients with coronary artery disease","volume":"100","author":"Ndrepepa","year":"2011","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.cca.2019.02.022_bb0790","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jocn.2005.10.016","article-title":"Metoprolol treatment decreases tissue myeloperoxidase activity after spinal cord injury in rats","volume":"14","author":"Beril Gok","year":"2007","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.cca.2019.02.022_bb0795","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0014-2999(00)00641-5","article-title":"Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model","volume":"406","author":"Gao","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cca.2019.02.022_bb0800","first-page":"790","article-title":"Inhibition of superoxide generation and myeloperoxidase release by carvedilol after receptor and nonreceptor stimulation of human neutrophils","volume":"29","author":"Macickova","year":"2008","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.cca.2019.02.022_bb0805","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jss.2006.11.021","article-title":"Statins inhibit neutrophil infiltration in skeletal muscle reperfusion injury","volume":"141","author":"Cowled","year":"2007","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.cca.2019.02.022_bb0810","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.bbrc.2005.03.204","article-title":"Statins downregulate myeloperoxidase gene expression in macrophages","volume":"331","author":"Kumar","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2019.02.022_bb0815","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.atherosclerosis.2009.10.046","article-title":"Effects of rosuvastatin on myeloperoxidase levels in patients with chronic heart failure: a randomized placebo-controlled study","volume":"210","author":"Andreou","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2019.02.022_bb0820","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cca.2005.12.040","article-title":"The effect of atorvastatin on serum myeloperoxidase and CRP levels in patients with acute coronary syndrome","volume":"368","author":"Zhou","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2019.02.022_bb0825","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2215\/CJN.01281005","article-title":"Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients","volume":"1","author":"Stenvinkel","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2019.02.022_bb0830","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/clc.20732","article-title":"Changes in inflammatory biomarkers in patients treated with ticagrelor or clopidogrel","volume":"33","author":"Husted","year":"2010","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.cca.2019.02.022_bb0835","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1172\/JCI119379","article-title":"3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima","volume":"99","author":"Hazen","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2019.02.022_bb0840","doi-asserted-by":"crossref","first-page":"47562","DOI":"10.1074\/jbc.M308428200","article-title":"Class B scavenger receptors CD36 and SR-BI are receptors for hypochlorite-modified low density lipoprotein","volume":"278","author":"Marsche","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2019.02.022_bb0845","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1074\/jbc.272.3.1433","article-title":"Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima","volume":"272","author":"Leeuwenburgh","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2019.02.022_bb0850","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1042\/CS20080322","article-title":"Myeloperoxidase-mediated lipoprotein carbamylation as a mechanistic pathway for atherosclerotic vascular disease","volume":"116","author":"Sirpal","year":"2009","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.cca.2019.02.022_bb0855","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1310\/hct0903-207","article-title":"Higher plasma myeloperoxidase levels are not associated with an increased risk for cardiovascular events in HIV-infected adults","volume":"9","author":"El-Bejjani","year":"2008","journal-title":"HIV Clin. Trials"},{"key":"10.1016\/j.cca.2019.02.022_bb0860","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.redox.2017.08.004","article-title":"Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction","volume":"13","author":"Abdo","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.cca.2019.02.022_bb0865","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/01.ATV.0000148703.43429.25","article-title":"2-chlorohexadecanal derived from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesis","volume":"24","author":"Marsche","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2019.02.022_bb0870","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1096\/fj.01-0273rev","article-title":"Oxidized LDL and HDL: antagonists in atherothrombosis","volume":"15","author":"Mertens","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.cca.2019.02.022_bb0875","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1194\/jlr.R039297","article-title":"Cardioprotective functions of HDLs","volume":"55","author":"Rye","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2019.02.022_bb0880","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MED.0b013e32832922fc","article-title":"Dysfunctional high-density lipoprotein","volume":"16","author":"Feng","year":"2009","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.cca.2019.02.022_bb0885","doi-asserted-by":"crossref","first-page":"13032","DOI":"10.1073\/pnas.0405292101","article-title":"The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport","volume":"101","author":"Bergt","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cca.2019.02.022_bb0890","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1074\/jbc.M407019200","article-title":"Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages","volume":"280","author":"Zheng","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2019.02.022_bb0895","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1021\/tx9003775","article-title":"Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein","volume":"23","author":"Shao","year":"2010","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cca.2019.02.022_bb0900","doi-asserted-by":"crossref","first-page":"30825","DOI":"10.1074\/jbc.M109.047605","article-title":"Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle","volume":"284","author":"Undurti","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2019.02.022_bb0905","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/01.ATV.0000163262.83456.6d","article-title":"Myeloperoxidase and cardiovascular disease","volume":"25","author":"Nicholls","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2019.02.022_bb0910","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1161\/01.CIR.0000140262.20831.8F","article-title":"Serum myeloperoxidase levels independently predict endothelial dysfunction in humans","volume":"110","author":"Vita","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2019.02.022_bb0915","doi-asserted-by":"crossref","first-page":"9P","DOI":"10.1016\/j.amjcard.2006.09.015","article-title":"Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease","volume":"98","author":"Tsimikas","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cca.2019.02.022_bb0920","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI117342","article-title":"Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions","volume":"94","author":"Daugherty","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2019.02.022_bb0925","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/01.CIR.0000042674.89762.20","article-title":"Neutrophil infiltration of culprit lesions in acute coronary syndromes","volume":"106","author":"Naruko","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2019.02.022_bb0930","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.atherosclerosis.2013.11.075","article-title":"Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: insights from intravascular ultrasound","volume":"232","author":"Kataoka","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2019.02.022_bb0935","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1093\/eurheartj\/ehy419","article-title":"Myeloperoxidase is a potential molecular imaging and therapeutic target for the identification and stabilization of high-risk atherosclerotic plaque","volume":"39","author":"Rashid","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2019.02.022_bb0940","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1126\/science.2982211","article-title":"Oxidative autoactivation of latent collagenase by human neutrophils","volume":"227","author":"Weiss","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.cca.2019.02.022_bb0945","doi-asserted-by":"crossref","first-page":"31826","DOI":"10.1074\/jbc.M704894200","article-title":"Myeloperoxidase inactivates TIMP-1 by oxidizing its N-terminal cysteine residue: an oxidative mechanism for regulating proteolysis during inflammation","volume":"282","author":"Wang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2019.02.022_bb0950","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1161\/01.ATV.0000131784.50633.4f","article-title":"Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis","volume":"24","author":"Sugiyama","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2019.02.022_bb0955","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12944-016-0388-z","article-title":"Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration","volume":"16","author":"Zhou","year":"2017","journal-title":"Lipids Health Dis."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119300841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119300841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:47:25Z","timestamp":1757861245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898119300841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":191,"alternative-id":["S0009898119300841"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2019.02.022","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myeloperoxidase \u2013 A bridge linking inflammation and oxidative stress with cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2019.02.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}